Home
Explore NIH Technologies
Explore work by over 1,500 NIH researchers | Available for Licensing & Collaboration
News
All are invited to attend the NCI Technology Transfer Center’s upcoming technology opportunity webinar entitled, “Proteolysis Targeting Chimeras (PROTACs) Targeting PIM Kinase for the Treatment of Cancer,” on April 24, from 11:00 a.m. to 12:00 p.m. The inventor, S enior Investigator, Dr. John
MedInvest is hosting a Biotech and Pharma Investor Conference April 3-4, 2024 in New York City. NIH’s Steve Ferguson and Michael Salgaller will be speaking. This is a great opportunity to learn about NIH as a premier technology transfer partner, how the process at the NIH works, and a chance to ask
NIH OTT's Steve Ferguson will be speaking at the NIH-KWiSE (Korean-American Women in Science and Engineering, NIH Chapter) Biotech Intellectual Property Forum on March 21, 2024. What is technology transfer/business development and what are the career opportunities in the field? What are the skills
Register to attend a free NCI webinar. Attendees will learn about a new a djuvanted subunit mucosal Covid-19 vaccine. Study results show that this new vaccine prevents SARS-CoV-2 transmission and infection. Most SARS-CoV-2 vaccines focus on delivering immunization through an intramuscular injection
Explore Featured Research
Get updates on the latest and most exciting research coming out of NIH...
Explore Featured Products
Novel and interesting products coming to market through NIH inventions and partnerships...